When medical aesthetics organizations evaluate inventory, the conversation typically revolves around cost of goods sold (COGS). While controlling product costs is important, focusing exclusively on COGS can overlook other factors that have a meaningful impact on financial performance. Inventory decisions influence cash flow, operational efficiency, provider productivity, and the patient experience. As organizations grow, add providers, or expand across multiple locations, inventory management becomes more complex. Leaders must balance product availability with cost control while ensuring they have the right products in the right place at the right time.
Business owners ask questions such as:
- Can we negotiate better pricing with our vendors?
- Should we switch to a lower-cost product?
- Are we maintaining our target margins on injectables and retail products?
- How can we reduce these costs?
These are important questions. COGS directly impacts profitability, and managing expenses is an essential part of running a successful practice. However, focusing exclusively on COGS can cause organizations to overlook a much larger financial opportunity: The amount of cash tied up in inventory.
COGS often receives the majority of management attention because it directly impacts profitability. However, inventory represents cash that has already left the business and has not yet generated a return. Until those products are used in a treatment or sold to a patient, that cash remains tied up on the shelf.
How Did We End Up Here?
If you’ve ever purchased extra filler to qualify for a rebate, stocked up on skincare products before a price increase, or ordered additional consumables “just to be safe,” you’re not alone. These 
decisions are made every day in medical aesthetics practices across the country. However, what starts as a smart purchasing decision can gradually turn into a cash-flow issue when products begin accumulating faster than they’re being sold or used.
When Inventory Starts Working Against You
Having the right products available when patients need them is critical. But when inventory levels exceed actual demand, the consequences can extend far beyond the supply room. Excess inventory can restrict cash flow, increase the risk of waste, and create a false sense of financial security, ultimately limiting a practice’s ability to invest in growth opportunities.
Reduced Cash Availability
Cash invested in excess inventory cannot be used elsewhere in the organization. That means fewer resources available for:
- Hiring and retention initiatives
- Equipment investments
- Marketing programs
- Facility improvements
- Expansion opportunities
Increased Waste
The longer products remain on the shelf, the greater the risk of:
- Expiration
- Damage
- Obsolescence
- Shrinkage
False Financial Security
A medical aesthetics practice may appear profitable on paper while simultaneously experiencing cash-flow constraints because too much working capital is trapped in inventory.
Why Inventory Turns in Medical Aesthetics Matter
One of the most effective ways to evaluate inventory performance is through inventory turns.
Inventory turns measure how many times inventory is sold and replaced over a given period.
The formula is straightforward:
Inventory Turns = Cost of Goods Sold ÷ Average Inventory
Inventory turns provide valuable insight into how efficiently products move through a practice. Generally, higher inventory turns indicate that products are being used or sold at a healthy pace, allowing cash to flow back into the business more quickly. Conversely, lower inventory turns may suggest excess inventory, inefficient purchasing habits, or slow-moving products that tie up valuable working capital.
While it may seem that the highest-possible inventory turn rate is always desirable, the objective is not simply to minimize inventory. Instead, successful organizations strive to find the right balance between maximizing cash-flow efficiency and maintaining sufficient product availability to meet patient demand.
A Practical Example
Consider two practices that each spend $1M annually on COGS.
Practice A
- Average Inventory: $125,000
- Inventory Turns: 8x annually
Practice B
- Average Inventory: $250,000
- Inventory Turns: 4x annually
Both practices purchase the same amount of product. However, Practice B has an additional $125,000 tied up on the shelf.
That’s $125,000 unavailable for strategic initiatives, staffing investments, or growth opportunities. The difference isn’t purchasing power; the difference is inventory management.
Cost Management vs. Cash Management Mindset
More financially successful medical aesthetics organizations understand that inventory optimization is not simply a procurement exercise—it is a working capital strategy.
Reducing COGS may improve margins, but managing inventory effectively improves cash flow. Organizations that understand this distinction often focus on:
- Establishing target inventory levels
- Monitoring inventory turns by category
- Standardizing ordering processes
- Identifying slow-moving products
- Reducing duplicate product offerings
- Leveraging vendor relationships strategically rather than reactively
The benefits often reach well beyond what’s sitting on your shelves.
Pull-Through Strategies: Turning Inventory into Revenue
Many medical aesthetics organizations evaluate vendor relationships based primarily on pricing, rebates, and volume incentives. While these programs can improve margins, they often encourage larger purchases without addressing the more important question: How quickly will those products generate revenue?
A pull-through strategy is any initiative designed to move toxins, fillers, skincare, and more through the business more efficiently by increasing appropriate patient adoption and treatment volume. The objective is not simply to acquire a cheaper COGS, but to create operational and commercial conditions that allow those COGS to generate revenue and return cash to the organization more quickly.
Examples may include:
- Patient education programs
- Provider training and treatment adoption initiatives
- Promotional campaigns
- Membership and loyalty programs
- Treatment bundling strategies
- Seasonal marketing efforts
- Patient reactivation campaigns
The financial impact can be significant. A rebate may improve the cost of a product by a few percentage points.
A successful pull-through strategy can increase utilization, accelerate cash conversion, and improve overall return on invested inventory.
Inventory Management as a Strategic Lever
Traditionally, COGS management has focused on reducing costs through rebates, discounts, and vendor negotiations. Why is this the default behavior? Because it is the easiest thing to do. Everyone can negotiate with vendors—and they should. Rebates, discounts, and preferred pricing agreements can certainly improve margins and reduce expenses. However, these strategies are easily replicated by competitors and rarely create a lasting competitive advantage.
Unlike a manufacturer discount, which can be negotiated in a single conversation, improving inventory efficiency requires ongoing attention from leadership and coordination across the organization. Providers, practice administrators, finance teams, and purchasing managers must all work from the same data and toward the same objectives.
Reducing COGS is important, but focusing on COGS alone can cause medical aesthetics practices to miss a much larger financial opportunity. The practices that consistently outperform their peers are often the ones converting inventory into revenue and cash more efficiently, not the ones purchasing inventory at the lowest price. In the end, inventory management is not simply a purchasing function; it is a working capital strategy.
In medical aesthetics, reducing costs is only the beginning. Connect with VMG Health to optimize inventory, improve cash flow, and identify operational opportunities for long-term growth.
